Personalized prediction for a 29 year old man who takes Nicotine, Wellbutrin Xl, Vistaril, Zoloft, Trazodone Hydrochloride, Seroquel, Campral, Baclofen, Lisinopril (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

What are the drugs?

Nicotine has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 20,441 Nicotine users. Check the latest studies of Nicotine.
Wellbutrin xl has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 22,961 Wellbutrin xl users. Check the latest studies of Wellbutrin xl.
Vistaril has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 9,562 Vistaril users. Check the latest studies of Vistaril.
Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,778 Zoloft users. Check the latest studies of Zoloft.
Trazodone hydrochloride has active ingredients of trazodone hydrochloride. It is often used in insomnia. eHealthMe is studying from 22,989 Trazodone hydrochloride users. Check the latest studies of Trazodone hydrochloride.
Seroquel has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. eHealthMe is studying from 120,271 Seroquel users. Check the latest studies of Seroquel.
Campral has active ingredients of acamprosate calcium. It is often used in alcoholism. eHealthMe is studying from 1,006 Campral users. Check the latest studies of Campral.
Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,648 Baclofen users. Check the latest studies of Baclofen.
Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,591 Lisinopril users. Check the latest studies of Lisinopril.

What are the conditions?

Cessation of smoking is found to be associated with 969 drugs and 937 conditions by eHealthMe. Check the latest studies of Cessation of smoking.
Depression is found to be associated with 3,222 drugs and 4,060 conditions by eHealthMe. Check the latest studies of Depression.
Anxiety is found to be associated with 4,618 drugs and 5,410 conditions by eHealthMe. Check the latest studies of Anxiety.
Sleeping is found to be associated with 4,404 drugs and 5,152 conditions by eHealthMe. Check the latest studies of Sleeping.
Insomnia (sleeplessness) is found to be associated with 3,133 drugs and 5,134 conditions by eHealthMe. Check the latest studies of Insomnia.
High blood pressure is found to be associated with 3,520 drugs and 5,207 conditions by eHealthMe. Check the latest studies of High blood pressure.
Restless leg is found to be associated with 2,355 drugs and 1,977 conditions by eHealthMe. Check the latest studies of Restless leg.
Alcohol use is found to be associated with 1,346 drugs and 1,329 conditions by eHealthMe. Check the latest studies of Alcohol use.

Potential side effects:

Abnormal dreams

7.89% for males aged 29 (±5) who have restless leg and cessation of smoking
5.97% for males aged 29 (±5) who have cessation of smoking and alcohol use

Aggression

10.42% for males aged 29 (±5) who have restless leg and cessation of smoking
8.18% for males aged 29 (±5) who have cessation of smoking and alcohol use
6.8% for males aged 29 (±5) who have cessation of smoking and insomnia
6.8% for males aged 29 (±5) who have cessation of smoking and sleeping
5.74% for males aged 29 (±5) who have cessation of smoking and depression
5.71% for males aged 29 (±5) who have anxiety and cessation of smoking
5.48% for males aged 29 (±5) who have cessation of smoking and high blood pressure

Agitation

5.9% for males aged 29 (±5) who have restless leg and anxiety
5.72% for males aged 29 (±5) who have anxiety and depression
5.71% for males aged 29 (±5) who have anxiety and insomnia
5.71% for males aged 29 (±5) who have anxiety and sleeping
5.59% for males aged 29 (±5) who have anxiety and cessation of smoking
5.43% for males aged 29 (±5) who have restless leg and depression
5.34% for males aged 29 (±5) who have anxiety and alcohol use
5.33% for males aged 29 (±5) who have cessation of smoking and depression
5.3% for males aged 29 (±5) who have insomnia and depression
5.3% for males aged 29 (±5) who have sleeping and depression
5.15% for males aged 29 (±5) who have depression and alcohol use

Alcoholism

14.05% for males aged 29 (±5) who have restless leg and alcohol use
5.4% for males aged 29 (±5) who have cessation of smoking and alcohol use
5.21% for males aged 29 (±5) who have insomnia and alcohol use
5.21% for males aged 29 (±5) who have sleeping and alcohol use

Anger

5.17% for males aged 29 (±5) who have restless leg and cessation of smoking

Appetite - increased

10.77% for males aged 29 (±5) who have restless leg

Arrhythmias

5.07% for males aged 29 (±5) who have insomnia and sleeping

Arthropathy

5.38% for males aged 29 (±5) who have restless leg

Balance disorder

6.92% for males aged 29 (±5) who have restless leg

Depression

16.67% for males aged 29 (±5) who have restless leg and cessation of smoking
13.04% for males aged 29 (±5) who have cessation of smoking and alcohol use
11.65% for males aged 29 (±5) who have cessation of smoking and insomnia
11.65% for males aged 29 (±5) who have cessation of smoking and sleeping
10.22% for males aged 29 (±5) who have anxiety and cessation of smoking
9.66% for males aged 29 (±5) who have cessation of smoking and depression
9.63% for males aged 29 (±5) who have cessation of smoking and high blood pressure
7.91% for males aged 29 (±5) who have restless leg and depression
7.46% for males aged 29 (±5) who have restless leg and anxiety
7.44% for males aged 29 (±5) who have depression and alcohol use
7.28% for males aged 29 (±5) who have insomnia and depression
7.28% for males aged 29 (±5) who have sleeping and depression
7.24% for males aged 29 (±5) who have anxiety and depression
6.82% for males aged 29 (±5) who have anxiety and insomnia
6.82% for males aged 29 (±5) who have anxiety and sleeping
6.71% for males aged 29 (±5) who have anxiety and alcohol use
6.69% for males aged 29 (±5) who have depression and high blood pressure
6.24% for males aged 29 (±5) who have insomnia and sleeping
6.2% for males aged 29 (±5) who have restless leg and insomnia
6.2% for males aged 29 (±5) who have restless leg and sleeping
5.83% for males aged 29 (±5) who have anxiety and high blood pressure
5.36% for males aged 29 (±5) who have insomnia and alcohol use
5.36% for males aged 29 (±5) who have sleeping and alcohol use

Diarrhea

6.92% for males aged 29 (±5) who have restless leg

Dizziness

7.0% for males aged 29 (±5) who have restless leg and anxiety
6.66% for males aged 29 (±5) who have anxiety and cessation of smoking
6.29% for males aged 29 (±5) who have anxiety and alcohol use
6.24% for males aged 29 (±5) who have anxiety and insomnia
6.24% for males aged 29 (±5) who have anxiety and sleeping
6.24% for males aged 29 (±5) who have anxiety and high blood pressure
6.1% for males aged 29 (±5) who have restless leg and cessation of smoking
5.92% for males aged 29 (±5) who have anxiety and depression
5.37% for males aged 29 (±5) who have cessation of smoking and depression
5.28% for males aged 29 (±5) who have cessation of smoking and insomnia
5.28% for males aged 29 (±5) who have cessation of smoking and sleeping
5.26% for males aged 29 (±5) who have restless leg and depression
5.26% for males aged 29 (±5) who have cessation of smoking and high blood pressure
5.16% for males aged 29 (±5) who have restless leg and high blood pressure
5.16% for males aged 29 (±5) who have depression and high blood pressure
5.12% for males aged 29 (±5) who have insomnia and depression
5.12% for males aged 29 (±5) who have sleeping and depression
5.11% for males aged 29 (±5) who have cessation of smoking and alcohol use

Drowsiness

5.04% for males aged 29 (±5) who have restless leg and insomnia
5.04% for males aged 29 (±5) who have restless leg and sleeping

Drug abuse and dependence

5.41% for males aged 29 (±5) who have insomnia and alcohol use
5.41% for males aged 29 (±5) who have sleeping and alcohol use
5.24% for males aged 29 (±5) who have insomnia and sleeping
5.13% for males aged 29 (±5) who have restless leg and alcohol use
5.04% for males aged 29 (±5) who have restless leg and insomnia
5.04% for males aged 29 (±5) who have restless leg and sleeping

Drug ineffective

8.47% for males aged 29 (±5) who have restless leg and anxiety
8.16% for males aged 29 (±5) who have anxiety and insomnia
8.16% for males aged 29 (±5) who have anxiety and sleeping
7.96% for males aged 29 (±5) who have insomnia and sleeping
7.95% for males aged 29 (±5) who have restless leg and insomnia
7.95% for males aged 29 (±5) who have restless leg and sleeping
7.79% for males aged 29 (±5) who have anxiety and alcohol use
7.56% for males aged 29 (±5) who have anxiety and cessation of smoking
7.55% for males aged 29 (±5) who have anxiety and depression
7.33% for males aged 29 (±5) who have restless leg and depression
7.31% for males aged 29 (±5) who have anxiety and high blood pressure
7.25% for males aged 29 (±5) who have insomnia and depression
7.25% for males aged 29 (±5) who have sleeping and depression
7.05% for males aged 29 (±5) who have depression and alcohol use
6.99% for males aged 29 (±5) who have cessation of smoking and depression
6.93% for males aged 29 (±5) who have insomnia and alcohol use
6.93% for males aged 29 (±5) who have sleeping and alcohol use
6.89% for males aged 29 (±5) who have depression and high blood pressure
6.82% for males aged 29 (±5) who have cessation of smoking and insomnia
6.82% for males aged 29 (±5) who have cessation of smoking and sleeping
6.66% for males aged 29 (±5) who have insomnia and high blood pressure
6.66% for males aged 29 (±5) who have sleeping and high blood pressure
6.27% for males aged 29 (±5) who have restless leg and high blood pressure
5.93% for males aged 29 (±5) who have cessation of smoking and high blood pressure
5.83% for males aged 29 (±5) who have restless leg and cessation of smoking
5.78% for males aged 29 (±5) who have alcohol use and high blood pressure
5.62% for males aged 29 (±5) who take nicotine
5.62% for males aged 29 (±5) who take wellbutrin xl
5.62% for males aged 29 (±5) who take vistaril
5.62% for males aged 29 (±5) who take zoloft
5.62% for males aged 29 (±5) who take trazodone hydrochloride
5.62% for males aged 29 (±5) who take seroquel
5.62% for males aged 29 (±5) who take campral
5.62% for males aged 29 (±5) who take baclofen
5.62% for males aged 29 (±5) who take lisinopril
5.37% for males aged 29 (±5) who have cessation of smoking and alcohol use

Emotional distress

5.38% for males aged 29 (±5) who have restless leg

Fall

5.38% for males aged 29 (±5) who have restless leg

Fatigue

6.77% for males aged 29 (±5) who have restless leg and anxiety
6.64% for males aged 29 (±5) who have anxiety and alcohol use
6.28% for males aged 29 (±5) who have anxiety and depression
6.17% for males aged 29 (±5) who have anxiety and cessation of smoking
6.15% for males aged 29 (±5) who have anxiety and insomnia
6.15% for males aged 29 (±5) who have anxiety and sleeping
6.14% for males aged 29 (±5) who have restless leg and depression
6.1% for males aged 29 (±5) who have depression and alcohol use
6.04% for males aged 29 (±5) who have insomnia and depression
6.04% for males aged 29 (±5) who have sleeping and depression
5.99% for males aged 29 (±5) who have anxiety and high blood pressure
5.89% for males aged 29 (±5) who have restless leg and alcohol use
5.84% for males aged 29 (±5) who have cessation of smoking and depression
5.8% for males aged 29 (±5) who have depression and high blood pressure
5.21% for males aged 29 (±5) who have insomnia and alcohol use
5.21% for males aged 29 (±5) who have sleeping and alcohol use
5.17% for males aged 29 (±5) who have cessation of smoking and alcohol use

Feeling abnormal

5.4% for males aged 29 (±5) who have restless leg and cessation of smoking
5.3% for males aged 29 (±5) who have restless leg and anxiety
5.3% for males aged 29 (±5) who have anxiety and cessation of smoking
5.09% for males aged 29 (±5) who have anxiety and alcohol use
5.05% for males aged 29 (±5) who have cessation of smoking and alcohol use

Head injury

5.38% for males aged 29 (±5) who have restless leg

Headache

6.8% for males aged 29 (±5) who have restless leg and anxiety
6.32% for males aged 29 (±5) who have anxiety and insomnia
6.32% for males aged 29 (±5) who have anxiety and sleeping
6.24% for males aged 29 (±5) who have anxiety and alcohol use
6.14% for males aged 29 (±5) who have anxiety and cessation of smoking
5.93% for males aged 29 (±5) who have anxiety and high blood pressure
5.78% for males aged 29 (±5) who have anxiety and depression
5.33% for males aged 29 (±5) who have restless leg and depression
5.3% for males aged 29 (±5) who have insomnia and depression
5.3% for males aged 29 (±5) who have sleeping and depression
5.18% for males aged 29 (±5) who have cessation of smoking and depression
5.15% for males aged 29 (±5) who have depression and high blood pressure
5.14% for males aged 29 (±5) who have depression and alcohol use
5.12% for males aged 29 (±5) who have restless leg and insomnia
5.12% for males aged 29 (±5) who have restless leg and sleeping
5.03% for males aged 29 (±5) who have insomnia and sleeping

High blood pressure

8.54% for males aged 29 (±5) who have restless leg and high blood pressure
6.98% for males aged 29 (±5) who have alcohol use and high blood pressure
6.28% for males aged 29 (±5) who have insomnia and high blood pressure
6.28% for males aged 29 (±5) who have sleeping and high blood pressure
5.63% for males aged 29 (±5) who have cessation of smoking and high blood pressure
5.23% for males aged 29 (±5) who have anxiety and high blood pressure

Hypersensitivity

5.38% for males aged 29 (±5) who have restless leg

Hypoaesthesia

6.15% for males aged 29 (±5) who have restless leg

Injection site pain

12.53% for males aged 29 (±5) who have restless leg and alcohol use

Injection site reaction

15.56% for males aged 29 (±5) who have restless leg and alcohol use
5.41% for males aged 29 (±5) who have insomnia and alcohol use
5.41% for males aged 29 (±5) who have sleeping and alcohol use
5.34% for males aged 29 (±5) who have cessation of smoking and alcohol use

Insomnia

12.63% for males aged 29 (±5) who have restless leg and insomnia
12.63% for males aged 29 (±5) who have restless leg and sleeping
12.49% for males aged 29 (±5) who have insomnia and sleeping
9.92% for males aged 29 (±5) who have insomnia and alcohol use
9.92% for males aged 29 (±5) who have sleeping and alcohol use
9.9% for males aged 29 (±5) who have cessation of smoking and insomnia
9.9% for males aged 29 (±5) who have cessation of smoking and sleeping
9.63% for males aged 29 (±5) who have anxiety and insomnia
9.63% for males aged 29 (±5) who have anxiety and sleeping
8.74% for males aged 29 (±5) who have restless leg and anxiety
8.15% for males aged 29 (±5) who have anxiety and cessation of smoking
7.85% for males aged 29 (±5) who have restless leg and cessation of smoking
7.79% for males aged 29 (±5) who have anxiety and alcohol use
7.35% for males aged 29 (±5) who have insomnia and depression
7.35% for males aged 29 (±5) who have sleeping and depression
6.76% for males aged 29 (±5) who have anxiety and depression
6.64% for males aged 29 (±5) who have insomnia and high blood pressure
6.64% for males aged 29 (±5) who have sleeping and high blood pressure
6.52% for males aged 29 (±5) who have cessation of smoking and alcohol use
6.41% for males aged 29 (±5) who have cessation of smoking and depression
6.26% for males aged 29 (±5) who have restless leg and depression
6.11% for males aged 29 (±5) who have anxiety and high blood pressure
5.94% for males aged 29 (±5) who have depression and alcohol use
5.19% for males aged 29 (±5) who have depression and high blood pressure
5.13% for males aged 29 (±5) who have restless leg and alcohol use

Memory loss

6.33% for males aged 29 (±5) who have insomnia and sleeping
6.16% for males aged 29 (±5) who have restless leg and insomnia
6.16% for males aged 29 (±5) who have restless leg and sleeping
5.47% for males aged 29 (±5) who have cessation of smoking and insomnia
5.47% for males aged 29 (±5) who have cessation of smoking and sleeping

Nausea

11.47% for males aged 29 (±5) who have restless leg and cessation of smoking
10.4% for males aged 29 (±5) who have cessation of smoking and alcohol use
8.38% for males aged 29 (±5) who have cessation of smoking and insomnia
8.38% for males aged 29 (±5) who have cessation of smoking and sleeping
8.22% for males aged 29 (±5) who have anxiety and cessation of smoking
7.82% for males aged 29 (±5) who have restless leg and alcohol use
7.45% for males aged 29 (±5) who have cessation of smoking and depression
7.31% for males aged 29 (±5) who have cessation of smoking and high blood pressure
6.73% for males aged 29 (±5) who have anxiety and alcohol use
6.65% for males aged 29 (±5) who have restless leg and anxiety
6.46% for males aged 29 (±5) who have depression and alcohol use
6.37% for males aged 29 (±5) who have restless leg and depression
6.37% for males aged 29 (±5) who have anxiety and depression
6.15% for males aged 29 (±5) who have anxiety and insomnia
6.15% for males aged 29 (±5) who have anxiety and sleeping
6.14% for males aged 29 (±5) who have insomnia and depression
6.14% for males aged 29 (±5) who have sleeping and depression
5.91% for males aged 29 (±5) who have insomnia and alcohol use
5.91% for males aged 29 (±5) who have sleeping and alcohol use
5.83% for males aged 29 (±5) who have depression and high blood pressure
5.51% for males aged 29 (±5) who have anxiety and high blood pressure
5.44% for males aged 29 (±5) who have restless leg and insomnia
5.44% for males aged 29 (±5) who have restless leg and sleeping
5.2% for males aged 29 (±5) who have insomnia and sleeping
5.02% for males aged 29 (±5) who have alcohol use and high blood pressure

Nausea and vomiting

9.23% for males aged 29 (±5) who have restless leg

Pain

5.97% for males aged 29 (±5) who have restless leg and alcohol use

Pathological gambling

6.15% for males aged 29 (±5) who have restless leg

Restless leg syndrome

6.92% for males aged 29 (±5) who have restless leg

Stress and anxiety

15.35% for males aged 29 (±5) who have restless leg and cessation of smoking
14.13% for males aged 29 (±5) who have restless leg and anxiety
14.06% for males aged 29 (±5) who have anxiety and cessation of smoking
12.54% for males aged 29 (±5) who have anxiety and alcohol use
12.44% for males aged 29 (±5) who have cessation of smoking and alcohol use
12.37% for males aged 29 (±5) who have anxiety and insomnia
12.37% for males aged 29 (±5) who have anxiety and sleeping
12.07% for males aged 29 (±5) who have cessation of smoking and insomnia
12.07% for males aged 29 (±5) who have cessation of smoking and sleeping
9.99% for males aged 29 (±5) who have anxiety and high blood pressure
9.67% for males aged 29 (±5) who have anxiety and depression
9.28% for males aged 29 (±5) who have cessation of smoking and depression
9.07% for males aged 29 (±5) who have restless leg and insomnia
9.07% for males aged 29 (±5) who have restless leg and sleeping
8.8% for males aged 29 (±5) who have insomnia and sleeping
8.78% for males aged 29 (±5) who have cessation of smoking and high blood pressure
8.02% for males aged 29 (±5) who have insomnia and depression
8.02% for males aged 29 (±5) who have sleeping and depression
7.92% for males aged 29 (±5) who have restless leg and depression
7.68% for males aged 29 (±5) who have insomnia and alcohol use
7.68% for males aged 29 (±5) who have sleeping and alcohol use
7.57% for males aged 29 (±5) who have depression and alcohol use
6.77% for males aged 29 (±5) who have depression and high blood pressure
6.06% for males aged 29 (±5) who have restless leg and alcohol use
5.93% for males aged 29 (±5) who have insomnia and high blood pressure
5.93% for males aged 29 (±5) who have sleeping and high blood pressure

Suicidal ideation

7.49% for males aged 29 (±5) who have restless leg and depression
7.33% for males aged 29 (±5) who have cessation of smoking and depression
7.27% for males aged 29 (±5) who have restless leg and cessation of smoking
7.15% for males aged 29 (±5) who have anxiety and depression
6.86% for males aged 29 (±5) who have restless leg and anxiety
6.85% for males aged 29 (±5) who have depression and alcohol use
6.75% for males aged 29 (±5) who have anxiety and cessation of smoking
6.59% for males aged 29 (±5) who have insomnia and depression
6.59% for males aged 29 (±5) who have sleeping and depression
5.86% for males aged 29 (±5) who have anxiety and alcohol use
5.86% for males aged 29 (±5) who have depression and high blood pressure
5.56% for males aged 29 (±5) who have anxiety and insomnia
5.56% for males aged 29 (±5) who have anxiety and sleeping
5.51% for males aged 29 (±5) who have cessation of smoking and alcohol use
5.08% for males aged 29 (±5) who have cessation of smoking and insomnia
5.08% for males aged 29 (±5) who have cessation of smoking and sleeping

Suicide attempt

6.72% for males aged 29 (±5) who have restless leg and cessation of smoking
5.05% for males aged 29 (±5) who have cessation of smoking and alcohol use

Therapeutic response unexpected

7.69% for males aged 29 (±5) who have restless leg

Tremor

9.23% for males aged 29 (±5) who have restless leg

Urination - painful

5.38% for males aged 29 (±5) who have restless leg

Weakness

5.38% for males aged 29 (±5) who have restless leg

Weight increased

9.23% for males aged 29 (±5) who have restless leg

Potential co-existing conditions:

Diabetes

5.06% for males aged 29 (±5) who have restless leg and high blood pressure

Drug dependence

10.43% for males aged 29 (±5) who have restless leg and alcohol use

Fibromyalgia

5.38% for males aged 29 (±5) who have restless leg

Gastroesophageal reflux disease

6.77% for males aged 29 (±5) who have restless leg and high blood pressure
5.14% for males aged 29 (±5) who have alcohol use and high blood pressure

High blood cholesterol

6.2% for males aged 29 (±5) who have restless leg and high blood pressure

Kidney transplant

5.32% for males aged 29 (±5) who have restless leg and high blood pressure

Pain

8.79% for males aged 29 (±5) who have restless leg and insomnia
8.79% for males aged 29 (±5) who have restless leg and sleeping
8.72% for males aged 29 (±5) who have insomnia and sleeping
8.42% for males aged 29 (±5) who have restless leg and high blood pressure
8.25% for males aged 29 (±5) who have restless leg and anxiety
7.89% for males aged 29 (±5) who have insomnia and high blood pressure
7.89% for males aged 29 (±5) who have sleeping and high blood pressure
7.85% for males aged 29 (±5) who have anxiety and insomnia
7.85% for males aged 29 (±5) who have anxiety and sleeping
7.67% for males aged 29 (±5) who have anxiety and high blood pressure
6.78% for males aged 29 (±5) who have anxiety and alcohol use
6.44% for males aged 29 (±5) who have alcohol use and high blood pressure
6.4% for males aged 29 (±5) who have insomnia and alcohol use
6.4% for males aged 29 (±5) who have sleeping and alcohol use
6.05% for males aged 29 (±5) who have anxiety and cessation of smoking
5.69% for males aged 29 (±5) who have anxiety and depression
5.58% for males aged 29 (±5) who have cessation of smoking and high blood pressure
5.58% for males aged 29 (±5) who have insomnia and depression
5.58% for males aged 29 (±5) who have sleeping and depression
5.5% for males aged 29 (±5) who have depression and high blood pressure
5.45% for males aged 29 (±5) who have cessation of smoking and insomnia
5.45% for males aged 29 (±5) who have cessation of smoking and sleeping
5.08% for males aged 29 (±5) who have restless leg and depression

Restless leg syndrome

10.93% for males aged 29 (±5) who have restless leg and alcohol use
5.2% for males aged 29 (±5) who have restless leg and insomnia
5.2% for males aged 29 (±5) who have restless leg and sleeping
5.05% for males aged 29 (±5) who have restless leg and cessation of smoking

Schizophrenia

9.09% for males aged 29 (±5) who have restless leg and anxiety
8.8% for males aged 29 (±5) who have insomnia and sleeping
8.72% for males aged 29 (±5) who have anxiety and insomnia
8.72% for males aged 29 (±5) who have anxiety and sleeping
8.51% for males aged 29 (±5) who have restless leg and insomnia
8.51% for males aged 29 (±5) who have restless leg and sleeping
7.85% for males aged 29 (±5) who have anxiety and alcohol use
6.82% for males aged 29 (±5) who have anxiety and high blood pressure
6.61% for males aged 29 (±5) who have anxiety and depression
6.61% for males aged 29 (±5) who have insomnia and alcohol use
6.61% for males aged 29 (±5) who have sleeping and alcohol use
6.55% for males aged 29 (±5) who have anxiety and cessation of smoking
6.06% for males aged 29 (±5) who have insomnia and depression
6.06% for males aged 29 (±5) who have sleeping and depression
5.74% for males aged 29 (±5) who have insomnia and high blood pressure
5.74% for males aged 29 (±5) who have sleeping and high blood pressure
5.32% for males aged 29 (±5) who have restless leg and depression

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Shah Z, Londhe V, "Influence of various media on the dissolution profiles of immediate-release quetiapine tablets in India", Dissolution Technologies, 2016 Feb .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .
Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Shah Z, Londhe V, "Influence of various media on the dissolution profiles of immediate-release quetiapine tablets in India", Dissolution Technologies, 2016 Feb .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.